ADAR1 Capital Management reports Tenax Therapeutics common share purchase worth $1.38 million - TENX News | RalliesADAR1 Capital Management reports Tenax Therapeutics common share purchase worth $1.38 million
T
TENX• ADAR1 Capital Management increases Tenax Therapeutics stake
- ADAR1 Capital Management, a 10% owner, increased its stake in Tenax Therapeutics to 5,624,151 shares.
- The position rose through purchases totaling 770,333 shares at weighted-average prices near US$1.79 per share.
- Holdings are reported as indirect ownership through private investment funds managed by ADAR1 Capital Management.
•
